World-class medical research capabilities
At SYNLAB, we provide comprehensive support to research projects along the entire value chain. Through our unique operations model, individuals and institutions are guaranteed world-class medical research and analysis, which is underpinned by our strict adherence to the ISO 15189 laboratory standard. This assures that our test results are accurate and reliable. We are committed to delivering the highest standard of service across Nigeria.
Our key areas of strengths
Comprehensive test menu
SYNLAB offers tests across all the medical disciplines and specialties with more than 5,000 test offerings. These include tests that are basic to those related to genetics and personalized medicine.
SYNLAB has a national footprint that spans 12 states with representation and reach in all the geopolitical zones in the country. This ensures that our services are available at a location near you.
SYNLAB operates a sophisticated logistical network that connects regional, national, and international centres. This tested network assures excellent sample management and speedy delivery while maintaining an agile ability to distribute research-related materials across the country.
Robust sample storage
SYNLAB has a redundant capacity for storing samples at temperatures varying from 0 to minus 80 degrees on a platform of uninterrupted power support.
Automated information delivery
SYNLAB operates on a backbone of a laboratory information management system that allows easy electronic compilation and dissemination of biological and related information.
Our record in the research space includes logistic, storage, analytical and information management support for several international and national projects, including:
H3Africa is a consortium that facilitates fundamental research into diseases in the African continent while also developing infrastructure, resources, training and ethical guidelines to support sustainable African research. H3Africa aims to create and support a pan-continental network of laboratories that apply leading-edge research to the study of the relationship between environmental and genetic factors that determine disease susceptibility and drug responses in Africa.
Merck is a biopharmaceutical company that uses the power of leading-edge science to save and improve lives worldwide. For more than 130 years, Merck has developed important medicines and vaccines. Today, they are at the forefront of research to deliver innovative health solutions that advance the prevention and treatment of diseases in people and animals.
WHO is a United Nations agency that connects nations, partners and people to promote health, keep the world safe and serve the vulnerable. WHO leads global efforts to expand universal health coverage. It also directs and coordinates the world’s response to health emergencies.
IVON stands for Intravenous Versus Oral Iron for iron deficiency anaemia (IDA) in pregnant Nigerian Women. The IVON Trial is funded by the Bill and Melinda Gates Foundation to study the effectiveness of intravenous ferric carboxymaltose (intervention) versus oral ferrous sulphate (control) for treating anaemia and IDA in pregnancy. It also measures acceptability, feasibility, implementation outcomes and the cost-effectiveness of intravenous iron among pregnant Nigerian women with moderate and severe anaemia at 20–32 weeks gestation.
Are you interested in running a medical research project in Nigeria?
Reach out to us and let us discuss the options that are available to you.